2:16cv14005 • November 10, 2016
Class Period Start
February 29, 2016
Class Period End
November 3, 2016
PSLRA Deadline
January 10, 2017
Case Allegations
10b5
Statutes of Repose
Mar 1, 2019
Country
United States
Court
Federal Court
Please note that for cases in the settlement stage, claims are handled by the claims administrator and NOT Levi & Korsinsky. Any information or documentation previously provided to us does not constitute submission of a claim. If you need to file a claim, check the status of a claim, or have questions regarding distribution of settlement funds, please contact the claims administrator below.
Claim Deadline
September 23, 2019
Settlement Fund
$14,100,000
Settlement Status
Disbursed
Settlement Class
All persons or entities that PURCHASED DIPLOMAT PHARMACY, INC. (“DIPLOMAT” OR “COMPANY”) COMMON STOCK BETWEEN FEBRUARY 29, 2016 AND NOVEMBER 3, 2016, INCLUSIVE.
Claim Administrator
Gilardi & Co. LLC
Diplomat Securities Litigation
Claims Administrator
c/o Gilardi & Co. LLC
P.O. Box 404131
Louisville, KY 40233-4131
+1 866-431-2092
[email protected]
Settlement Website
-Hearing Date
August 20, 2019
Opt-out Deadline
July 30, 2019
Settlement Note
Download hereProof Of Claim
Download here
Aug 20, 2019
The court has approved the distribution of settlement funds to eligible class members. Investors with approved claims may receive payments from the settlement. If you have questions about your claim or payment, contact the claims administrator.
Aug 20, 2019
The court has granted final approval of the settlement. Eligible investors who submit valid claims may receive a payment once the claims review and distribution process is completed.
May 7, 2019
To receive your portion of the recovery (if you are eligible), you must submit this form to the claims administrator by the deadline indicated on the form itself. If you do not submit this form in time, you will not be entitled to compensation. If you have questions about how to complete the form, you should contact the claims administrator.
Apr 22, 2019
Jan 19, 2018
The court has denied the defendants' request to dismiss the lawsuit. The case can now move forward to the next stage of litigation.
May 26, 2017
After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.
Apr 11, 2017
A new complaint has been filed on behalf of certain investors in Diplomat Pharmacy, Inc.. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.
Feb 10, 2017
The court has appointed a lead plaintiff to represent the interests of investors in the lawsuit. The lead plaintiff works with the attorneys handling the case, helps oversee the litigation, and represents the interests of the proposed class.
Nov 10, 2016
A securities fraud class action complaint has been filed on behalf of certain investors in Diplomat Pharmacy, Inc..
TOP
